Cell Membrane-Camouflaged Nanoparticles Mediated Nucleic Acids Delivery
December 2023
in “
International Journal of Nanomedicine
”
Studysummary This study reviewed the challenges of delivering nucleic acids for gene therapy, highlighting the limitations of non-viral vehicles and exploring bioinspired strategies using cell membrane camouflage for improved delivery efficacy.
Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
The document explores the use of cell membrane-camouflaged nanoparticles (CMCNPs) for delivering nucleic acids in gene therapy, addressing challenges like degradation and targeting. CMCNPs, coated with membranes from cells such as erythrocytes, platelets, and macrophages, enhance biocompatibility, reduce immune recognition, and improve targeting and cellular uptake. These nanoparticles show promise in cancer therapy and inflammatory disease treatment by leveraging the unique properties of different cell membranes. Despite challenges like variability in membrane sources and potential immunogenicity, CMCNPs are expected to advance nucleic acid delivery systems, potentially revolutionizing gene therapy.
